Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension
Yi Ye, Qiying Xu, Tana Wuren
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Showing 18 citing articles:

The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications
Hui Zhao, Jialin Song, Xiujun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access | Times Cited: 1
Single cell transcriptomic analyses reveal diverse and dynamic changes of distinct populations of lung interstitial macrophages in hypoxia-induced pulmonary hypertension
Sushil Kumar, Claudia Mickael, Rahul Kumar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia
Kazufumi Nakamura, Satoshi Akagi, Kentaro Ejiri, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 835-835
Open Access
New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses
Xiaobo Su, Yunjuan Sun, Aiguo Dai
APOPTOSIS (2025)
Open Access
Omentin-1 as a promising biomarker and therapeutic target in hypertension and heart failure: a comprehensive review
Mohammad Yasin Zamanian, Saba Maleki, Enwa Felix Oghenemaro, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Exploring the mechanism of action of tolvaptan in the treatment of cor pulmonale pulmonary hypertension using network pharmacology and animal-based experiments
Juan Sun, Xiaoping Shao, Fei Yu, et al.
Letters in Drug Design & Discovery (2025), pp. 100002-100002
Open Access
Establishment of a lupus-prone mouse model of pulmonary arterial hypertension with intermittent hypoxia: functional, biochemical and histological verifications
Dengfeng Wu, Jiangbiao Xiong, Yiping Huang, et al.
Clinical and Experimental Hypertension (2025) Vol. 47, Iss. 1
Open Access
Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development
Abu Ahmed, Arlin B. Blood, Li Zhang
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 104015-104015
Open Access | Times Cited: 3
A peripheral system disease—Pulmonary hypertension
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 2
Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway
Chenyang Ran, Meili Lu, Fang Zhao, et al.
Journal of Ginseng Research (2024) Vol. 48, Iss. 4, pp. 405-416
Open Access | Times Cited: 1
T follicular helper cell is essential for M2 macrophage polarization and pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension
Cheng Li, Pingping Liu, Hao Zhu, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Inflammation and Macrophage Immunity in High Altitude Pulmonary Edema
佳文 李
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 4227-4233
Closed Access
Exosomes derived from hypoxic alveolar epithelial cells promote the phenotypic transformation of pulmonary artery smooth muscle cells via the Rap1 pathway
Guifang Sun, Fangyun Zhao, Yusen Feng, et al.
Experimental Lung Research (2024) Vol. 50, Iss. 1, pp. 160-171
Open Access
Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach
Ankita Mitra, Dan Yi, Zhiyu Dai, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors
Karen Flores, Carla Almeida, Karem Arriaza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11023-11023
Open Access
Promotor Hypomethylation Mediated Upregulation of VCAN Targets Twist1 to Promote EndMT in Hypoxia‐Induced Pulmonary Hypertension
Jinyan Yu, Shanchao Hong, Lingjia Yang, et al.
Journal of the American Heart Association (2024)
Closed Access
Zhishi Xiebai Guizhi Decoction modulates hypoxia and lipid toxicity to alleviate pulmonary vascular remodeling of pulmonary hypertension in rats
Min Fu, Yuan Li, Jingjing Liu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Immunomodulatory macrophages and Treg in pulmonary hypertension
Ayobami Matthew Olajuyin, Adefunke Kafayat Olajuyin, X. Zhang, et al.
Comparative Clinical Pathology (2023) Vol. 33, Iss. 1, pp. 163-173
Closed Access | Times Cited: 1
Page 1

Scroll to top